InterVenn Investigator Initiated Research Program in Glycoproteomics

"Novel Plasma Glycoprotein Biomarkers Predict Progression-free Survival in Surgically Resected Clear Cell Renal Cell Carcinoma"

— medRxiv

"Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19"

— medRxiv

"30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade"

— BMJ Publishing Group Ltd

"Differential Glycoprotein Profiles in Severe and Asymptomatic COVID-19"

— American Society for Mass Spectrometry, 2021

"Serum glycoprotein markers in Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma"

— bioRxiv

"Glycoproteomics as a Powerful Liquid Biopsy-based Predictor of Checkpoint-inhibitor Treatment Response"

— American Association for Cancer Research

"Site-Specific Glycosylation Quantitation of 50 Serum Glycoproteins Enhanced by Predictive Glycopeptidomics for Improved Disease Biomarker Discovery"

— ACS Publications

"PB-Net: Automatic peak integration by sequential deep learning for multiple reaction monitoring"

— ScienceDirect

"Serum glycoproteomic-based liquid biopsy for the detection of pancreatic ductal adenocarcinoma."

— Journal of Clinical Oncology